Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new avapro clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on avapro
- ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation
Status: Completed, Condition Summary: Myocardial Ischemia; Hypertension - Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
Status: Recruiting, Condition Summary: Hypertension - Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria
Status: Completed, Condition Summary: Albuminuria - Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
Status: Completed, Condition Summary: Metabolic Syndrome; Hypertension - Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)
Status: Completed, Condition Summary: Atrial Fibrillation - I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
Status: Recruiting, Condition Summary: Hypertension - I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
Status: Completed, Condition Summary: Hypertension - I PREVENT - Irbesartan In Hypertensive Diabetic Patients
Status: Recruiting, Condition Summary: Hypertension - Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
Status: Completed, Condition Summary: Hypertension - Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension
Status: Completed, Condition Summary: Hypertension - Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
Status: Active, not recruiting, Condition Summary: Congestive Heart Failure - Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate- to Severe Hypertensive Patients
Status: Recruiting, Condition Summary: Hypertension - A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus - Irbesartan in Hypertension
Status: Completed, Condition Summary: Hypertension - Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
Status: Active, not recruiting, Condition Summary: Atrial Fibrillation; Vascular Risk - Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)
Status: Terminated, Condition Summary: Atrial Fibrillation; Vascular Risk - Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
Status: Active, not recruiting, Condition Summary: Atrial Fibrillation; Cardiovascular Disease - Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
Status: Recruiting, Condition Summary: IGA Nephropathy - APROVE : Irbesartan in Hypertension
Status: Completed, Condition Summary: Hypertension - A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension
Status: Recruiting, Condition Summary: Hypertension - Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
Status: Active, not recruiting, Condition Summary: Hypertension - Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
Status: Active, not recruiting, Condition Summary: Hypertension - Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension
Status: Completed, Condition Summary: Hypertension - Irbesartan and Adhesion Molecules in AF
Status: Not yet recruiting, Condition Summary: Persistent Atrial Fibrillation - Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
Status: Completed, Condition Summary: Hypertension; Dyslipidemia - Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.
Status: Completed, Condition Summary: Essential Hypertension - AMISH : Aprovel for Management of Isolated Systolic Hypertension
Status: Completed, Condition Summary: Hypertension - Evaluating the Link Between Thiazide Medications, the Nervous System, and Diabetes in Individuals With High Blood Pressure
Status: Recruiting, Condition Summary: Hypertension - Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
Status: Completed, Condition Summary: Hypertension - Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
Status: Completed, Condition Summary: Diabetes Type 2